A Study of LC542019 in Healthy Subjects and Subjects With T2DM

Status:
COMPLETED

Trial end date:
2023-12-14

Target enrollment:

Participant gender:

to assess the safety, tolerability, Pharmacokinetics and Pharmacodynamics in healthy subjects and subjects with type 2 diabetes (T2DM).

PHASE1

LG Chem